A recently approved injectable drug can significantly stall deteriorating health among people newly diagnosed with the most severe form of high blood pressure, a new study says. Sotatercept reduced patient’s risk of deterioration by 76% due to pulmonary hypertension, or high blood pressure in the heart-to-lung system, researchers reported recently in the New England Journal…  read on >  read on >

Seasonal allergies are considered an annoyance to most, and maddening to some. Few think of seasonal sniffles and sneezes as potentially fatal — but we might be overlooking the danger they pose, a new study warns. High pollen counts are linked to a significant increase in suicide risk, according to findings published in the December…  read on >  read on >

A new low-cost version of the abortion pill mifepristone just received federal approval and it’s already stirring political controversy. The U.S. Food and Drug Administration (FDA) recently granted approval to Evita Solutions for its generic version of mifepristone, a medication used to end early pregnancies up to 10 weeks.  The original version of mifepristone has…  read on >  read on >

Long-term exposure to a chemical used in metal degreasing and dry cleaning might increase the risk of Parkinson’s disease, a new study says. Seniors living in places with the highest airborne levels of trichloroethylene showed a 10% higher risk for Parkinson’s than those in areas with the lowest levels, researchers report in the journal Neurology.…  read on >  read on >

People with extreme, life-threatening allergic reactions might do as well to use a nasal spray as jab themselves in a thigh with an EpiPen, a new evidence review says. Adrenaline delivered with liquid or powder nasal sprays is as effective, and sometimes even better, than injected adrenaline, researchers reported Tuesday at the European Emergency Medicine…  read on >  read on >